Laboratory services organization focuses on easing patient and site burden with improved collection device.
Chuck Drucker
Advertisement
Articles by Chuck Drucker
Operational and patient burden considerations for self-collection of blood specimens in clinical trials
A look at the future of clinical trial laboratory testing amid the emerging use of new devices at the point of care.
Over the past few years, there has been significant growth in the use of more complex point of care laboratory devices.
Advertisement
Latest Updated Articles
- At-home Self-collection of Blood Specimens for Safety Lab Testing in Clinical Trials via the Tasso+ Device
Published: February 1st 2023 | Updated:
Will Point of Care Laboratory Devices Replace Brick and Mortar Labs in Clinical Trials?Published: July 24th 2020 | Updated:
Self-collection of Blood Specimens in Clinical TrialsPublished: February 22nd 2021 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
2
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
3
Reducing Site Burden Through Better Technology Integration in Clinical Trials
4
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
